Glycobiology of laminin-integrin interaction and the metastatic phenotype.
Chammas
R
R
Instituto Ludwig de Pesquisa sobre o Câncer, São Paulo, Brasil.
Veiga
S S
SS
Brentani
R R
RR
D000818:Animals; D001485:Basement Membrane / Q000378:metabolism / Q000473:pathology; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism; D006031:Glycosylation; D016023:Integrins / Q000378:metabolism*; D007797:Laminin / Q000378:metabolism*; D008546:Melanoma, Experimental / Q000378:metabolism / Q000473:pathology; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis / Q000473:pathology; D009363:Neoplasm Proteins / Q000378:metabolism*; D009844:Oligosaccharides / Q000378:metabolism; D010641:Phenotype; D017474:Receptors, Laminin / Q000378:metabolism*; D016029:Receptors, Very Late Antigen / Q000378:metabolism; D017026:Swainsonine / Q000494:pharmacology; D014415:Tunicamycin / Q000494:pharmacology
D016023:Integrins; D007797:Laminin; D009363:Neoplasm Proteins; D009844:Oligosaccharides; D017474:Receptors, Laminin; D016029:Receptors, Very Late Antigen; D014415:Tunicamycin; D017026:Swainsonine